KRYS Earnings Krystal Biotech, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–25 of 25
| Q2 2026 | 2026-06-30 | 3.62 | 2026-08-03 | 10-Q |
| Q1 2026 | 2026-03-31 | 1.83 | 2026-05-04 | 10-Q |
| FY 2025 | 2025-12-31 | 6.84 | 2026-02-17 | 10-K |
| Q3 2025 | 2025-09-30 | 5.14 | 2025-11-03 | 10-Q |
| Q2 2026 | 2025-06-30 | 2.48 | 2026-08-03 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.20 | 2026-05-04 | 10-Q |
| FY 2025 | 2024-12-31 | 3.00 | 2026-02-17 | 10-K |
| Q3 2025 | 2024-09-30 | 1.47 | 2025-11-03 | 10-Q |
| Q2 2025 | 2024-06-30 | 0.56 | 2025-08-04 | 10-Q |
| Q1 2025 | 2024-03-31 | 0.03 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | 0.39 | 2026-02-17 | 10-K |
| Q3 2024 | 2023-09-30 | 0.08 | 2024-11-04 | 10-Q |
| Q2 2024 | 2023-06-30 | -3.00 | 2024-08-05 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.76 | 2024-05-06 | 10-Q |
| FY 2024 | 2022-12-31 | -5.49 | 2025-02-19 | 10-K |
| Q3 2023 | 2022-09-30 | -4.24 | 2023-11-06 | 10-Q |
| Q1 2023 | 2022-06-30 | -3.08 | 2023-08-07 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.99 | 2023-05-08 | 10-Q |
| FY 2023 | 2021-12-31 | -3.13 | 2024-02-26 | 10-K |
| Q3 2022 | 2021-09-30 | -2.18 | 2022-11-07 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.48 | 2022-08-08 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.74 | 2022-05-09 | 10-Q |
| FY 2021 | 2020-12-31 | -1.71 | 2023-02-27 | 10-K |
| Q3 2021 | 2020-09-30 | -1.18 | 2021-11-08 | 10-Q |
| Q2 2021 | 2020-06-30 | -0.68 | 2021-08-09 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.